Pharmalive - The Pulse of the Pharmaceutical Industry
Search Criteria: Search In:  
Conferences


R&D Directions Insider

Archive for March, 2010

Report: Fixing trial start-up woes requires new way of thinking

Friday, March 19th, 2010

Life sciences R&D is becoming an increasingly networked and externalized practice – just see the latest merger, licensing deal, or joint venture for proof. Therefore, experts say, it is even more critical for drug companies to rethink the way they mange the various components of a clinical trial, where several ...

Posted in CRO, clinical trials | 1 Comment »

Roche pipeline takes stage

Wednesday, March 17th, 2010

Top executives with the Swiss pharma giant, eager to shift attention from a series of recent clinical-trial setbacks, will be in New York City tomorrow for the company's first investor conference since its buyout of Genentech. They are expected to emphasize the potential created by Roche's new biotech arm and highlight several promising pipeline drugs, led by Phase III blockbuster candidates dalcetrapib, aleglitazar, and RG1678.  I will be on ...

Posted in Uncategorized, clinical trials | No Comments »

Hands-on training for SDTM conversion

Wednesday, March 10th, 2010

With FDA's adoption of a standardized data file format for clinical data submissions, clinical researchers need to know these new standards when collecting and preparing their clinical trial data for submission, since it is the only way that clinical data can be submitted. The ultimate purpose of using the Study ...

Posted in FDA | No Comments »

BMS investor day

Thursday, March 4th, 2010

You can follow us this afternoon on Twitter, where I'll be reporting live from the Bristol-Myers Squibb investor meeting in New York City. Fresh off news of his retirement, CEO Jim Cornelius will provide opening remarks. His successor, Lamberto Andreotti, will then present an overview of the company and its plans moving ...

Posted in Uncategorized | No Comments »

   
about us | advertise | contact us | home
terms of use | privacy | copyright | site map 		©2010 Canon Communications Pharmaceutical Media Group